GOLDSTONE CAP (01160): Two potential unlisted investment projects have been identified

GOLDSTONE CAP (01160) announced that it has identified two potential unlisted investment projects. Potential Project 1 - Biotechnology (Early Cancer Screening) The project company is located in Shenzhen and is engaged in the molecular diagnostics field, focusing on early cancer screening based on miRNA (microRNA) technology. Potential Project 2 - Advanced Manufacturing (Semiconductor Electronic Specialty Gases) The project company is located in Chongqing and focuses on ultra-high-purity electronic specialty gases for the semiconductor industry, and benefits from strong import substitution demand in China. The founder and core technical team have approximately 30 years of industry experience at internationally leading gas companies. According to information provided by the project company, it holds 52 patents, and its products have been certified and are directly supplied to approximately 30 12-inch wafer fabs globally, covering leading integrated device manufacturers and wafer foundries in the United States, mainland China, and Taiwan, China.